RAPID TREND SHIFT IN RADIOLOGY TECHNOLOGY AND ACCESSIBILITY
With
Dr Mansoor Parker,
Diagnostic & Interventional Radiologist & Founding Partner,
Quantum Radiology, Sydney &
Board Member,
Australian Diagnostic Imaging Association
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Sydney | October 2025
Dr Mansoor Parker obtained his medical degree from the University of Tasmania. He then completed his specialist radiology training at Nepean Hospital, Sydney with subspecialty interests in Interventional Radiology and Pain Management, Musculoskeletal, Cardiac and Abdominal Imaging. Dr Parker is a qualified specialist since 2005 and is a member of the Royal Australian and New Zealand College of Radiologists and the exclusive Australasian Musculoskeletal Imaging Group (AMSIG) as well as the Interventional Radiology Society of Australasia (IRSA).
Dr Parker has completed his Masters Training in Cardiac CT (Level B) and CT Colonography. He has also completed CT Colonography and Cardiac CT Angiography Accreditation obtaining Level 2 Society of Cardiovascular CT (CTCA), the highest level available in Australia. He sits on the board of directors of Australian Diagnostic Imaging Associated (ADIA) and is a committee member of the Medical Imaging Accreditation Scheme Advisory Committee (MIASAC) as part of the Australian Commission on Safety and Quality in Health Care.
Dr Mansoor Parker has been involved in developing CT Colonography software used on many CT machines today. Dr Parker is the founding partner of Quantum Radiology (founded in 2005) and serves in the position of the Chair of the Doctors Management Committee (DMC) at the Quantum Medscan Radiology Group
Source: Supplied
-
Changes in MBS bulk billing incentives address GP capacity in women’s health
Dr. Sneha Wadhwani, a General Practitioner in Bondi, and Conjoint Lecturer at UNSW School of Medicine, is actively involved in enhancing women’s health services across Australia. As the Co-founder and Clinical Director of Evoca Women’s Health, she highlights the significant improvements in funding for women’s health, particularly with the new MBS bulk billing incentives, in new codes, that commenced on November 1, 2025.
-
New reimagined identity LifeSciences Australia repositions for sector
In June 2026, ARCS Australia formally became LifeSciences Australia — a name chosen to reflect the role the organisation plays across Australia’s life sciences sector.
Over more than 40 years, ARCS has grown well beyond its origins as a training and education body for regulatory and clinical specialists. Today, the organisation supports professionals across the entire life sciences sector — from early research through regulation, development and commercialisation — through an expanding range of programs and initiatives.
-
Greater flexibility in medicine safety programs delivered by pharmacists
Addressing delegates at PSA26, the Pharmaceutical Society of Australia’s (PSA) yearly conference, the Minister for Health and Ageing, the Hon. Mark Butler MP, announced negotiations are progressing on the First Pharmacy Programs Agreement (1PPA), and that from 1 November, follow-up services for Home Medicines Reviews (HMRs) and Residential Medication Management Reviews (RMMRs) programs will be able to be delivered via telehealth.
